Stock listing
Kairos Pharma, Ltd.
Selected listing: KAPA · AMEX · USD · US
Kairos Pharma, Ltd. (NYSE American: KAPA), Health Technology. Latest release Oct 6, 2026: Kairos Pharma Reports Positive, Statistically Significant Interim…
- Ticker
- NYSE American: KAPA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE American
- Currency
- USD
About Kairos Pharma, Ltd.
The company is focused on developing innovative pharmaceutical solutions. Investors can find detailed information about its operations and market presence on its public company page.
Latest news from Kairos Pharma, Ltd.
Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer
October 6, 2026
Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
Kairos Pharma Announces 1-for-7 Reverse Stock Split
August 21, 2026
Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer
July 22, 2026
Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance Market
July 15, 2026